Transcranial Direct Current Stimulation (tDCS) and Parkinson's Disease

NCT ID: NCT01100762

Last Updated: 2019-10-30

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 10 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2010-01-31
• Study Completion Date: 2011-06-30

Brief Summary

The use of low level electrical stimulation when applied over the head, also called transcranial direct current stimulation (tDCS), is being tested by several groups of researchers to see if tDCS can improve movements of persons with damage to the brain. The safety and potential benefits of tDCS to children or adults patients who are paralyzed because of brain damage are reported in the medical literature. In addition, some patients with Parkinson's disease (PD) experience improvement in memory and report better use of the hand after tDCS. The treatment requires putting electrodes (pads) over the head and sending very small amount of electrical current that the patient may feel as "little tingling". Application of tDCS takes 20 min. In this study we wish to test if tDCS application can improve stepping and walking ability of subjects with PD and if the improvement is the same as when walking on treadmill. We plan to test the subject's ability to step when pulled by a laboratory testing system and also test his/her walking ability. There will be 3 sessions 7 days apart. In the first session the subject will be tested then treated for 20 min with tDCS and then tested again. In the second session the subject will be tested then walk on a treadmill for 20 min then tested again. In the third session the subject will be tested then walk on the treadmill for 20 min while receiving also tDCS and tested one last time at the end of the session. Each session will take between 2 and 3 hours.

Detailed Description

Recent advances in non-invasive electrical stimulation technology including transcranial direct current stimulation (tDCS) have provided novel and low risk options to rehabilitate the impaired ability of the central nervous system (CNS) to process sensorimotor information. Furthermore, tDCS appears to enhance CNS connectivity and there is preliminary evidence indicating that patients with Parkinson's Disease (PD) may experience improvement in working memory, the Unified Parkinson's Disease Rating Scale, simple reaction time and the Purdue Pegboard test. tDCS is inexpensive, portable and available for repeated home use. It may provide long-lasting enhancement of cortical activity in part because tDCS is easy to administer frequently and to combine it with other rehabilitation approaches including posture and gait training. However to date, no study has examined quantitatively the effects of tDCS on posture control and walking ability in patients with PD. As a first step we plan to identify the immediate effects of tDCS, as well as the added value of tDCS to treadmill exercise training, to improve posture and gait of individuals with PD.

Conditions

Parkinson's Disease

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: TREATMENT
• Blinding Strategy: NONE

Study Groups

Single Group

10 subjects with Parkinson's Disease receiving tPCS during the first session, treadmill walk, 7-10 days later (second session, and combined tPCS and treadmill 7-10 days week later (third session)

Group Type: EXPERIMENTAL

Cranial Electric Stimulation (CES)

Intervention Type: DEVICE

We will follow the procedure described by several investigators as safe and effective. The participant will sit on a standard chair. Two commercially available surface electrodes will be embedded in an elastic head cup. Each electrode will be covered with a water soaked absorbent fabric. One positive (+) electrode will be placed over the primary motor cortex (M1) and pre-motor areas. One negative (-) electrode will be placed over the skin overlying the contra lateral supra-orbital region. The electrodes will be connected via 2 leads to a battery powered direct current stimulator. The stimulator will be programmed to deliver 0.975mA (peak 4mA) over 20 minutes.

Treadmill

Intervention Type: DEVICE

The participant will walk on a treadmill for 20 minutes at the individually self-selected velocity determined at baseline.

CES and Treadmill

Intervention Type: DEVICE

Participants will have a combined session with CES while walking on the treadmill for 20 minutes at the individually self-selected velocity determined at baseline.

Interventions

Cranial Electric Stimulation (CES)

We will follow the procedure described by several investigators as safe and effective. The participant will sit on a standard chair. Two commercially available surface electrodes will be embedded in an elastic head cup. Each electrode will be covered with a water soaked absorbent fabric. One positive (+) electrode will be placed over the primary motor cortex (M1) and pre-motor areas. One negative (-) electrode will be placed over the skin overlying the contra lateral supra-orbital region. The electrodes will be connected via 2 leads to a battery powered direct current stimulator. The stimulator will be programmed to deliver 0.975mA (peak 4mA) over 20 minutes.

Intervention Type: DEVICE

Treadmill

The participant will walk on a treadmill for 20 minutes at the individually self-selected velocity determined at baseline.

Intervention Type: DEVICE

CES and Treadmill

Participants will have a combined session with CES while walking on the treadmill for 20 minutes at the individually self-selected velocity determined at baseline.

Intervention Type: DEVICE

Eligibility Criteria

Inclusion Criteria

• Diagnosis of adult onset of PD
• A history of freezing of gait (FOG) as evidence by clinical assessment
• A stable regimen of anti-parkinsonian medications
• Ability to walk at least 10m without assistance
• Ability to walk on a treadmill for 20 minutes
• Personal weight of less than 500 Lb (because the suspension harness over the treadmill is limited to 500 Lb
• Stage 3 of the Hoehn and Yahr disability scale
• A score of >24 on the Mini Mental State Examination

Exclusion Criteria

• Evidence of any clinically significant functional impairment related to cardiovascular, pulmonary, metabolic, other neurologic or musculoskeletal disease criterial that would preclude participation in training
• Any medical condition that might require other medical or surgical treatment during the study period
• A history of brain surgery or placement of a deep brain stimulator
• Dyskinesias > grade 2 on the Unified Parkinson's Disease Rating Scale (UPDRS)
• Any uncorrected vision or hearing problems that may limit daily activities or communication

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 85 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

University of Maryland, Baltimore

OTHER

Sponsor Role: lead

Responsible Party

Gad Alon

Associate Professor

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Gad Alon, PhD, PT

Role: PRINCIPAL_INVESTIGATOR

University of Maryland, Baltimore

Mark W Rogers, PhD, PT

Role: PRINCIPAL_INVESTIGATOR

University of Maryland, Baltimore

Lisa Shulman, MD

Role: PRINCIPAL_INVESTIGATOR

Univeristy of Maryland, Baltimore

Locations

PTRS Research Lab

Baltimore, Maryland, United States

Countries

United States

Other Identifiers

HP-00040670

Identifier Type: -

Identifier Source: org_study_id